Clovis Stock Future Price Prediction

CLVS
 Stock
  

USD 0.36  0.03  9.09%   

Clovis Oncology stock price prediction is an act of determining the future value of Clovis Oncology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Clovis Oncology's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Clovis Oncology and does not consider all of the tangible or intangible factors available from Clovis Oncology's fundamental data. We analyze noise-free headlines and recent hype associated with Clovis Oncology, which may create opportunities for some arbitrage if properly timed.
Continue to Clovis Oncology Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Clovis Oncology based on different types of headlines from major news networks to social media. The Clovis stock price prediction module provides an analysis of price elasticity to changes in media outlook on Clovis Oncology over a specific investment horizon.
EPS Estimate Next Quarter
(0.39) 
EPS Estimate Current Year
(1.61) 
EPS Estimate Next Year
(0.78) 
Wall Street Target Price
2.0
EPS Estimate Current Quarter
(0.41) 
Quarterly Revenue Growth YOY
(0.19) 
Using Clovis Oncology hype-based prediction, you can estimate the value of Clovis Oncology from the perspective of Clovis Oncology response to recently generated media hype and the effects of current headlines on its competitors.
Clovis Oncology Net Current Assets as percentage of Total Assets are relatively stable at the moment as compared to the past year. Clovis Oncology reported last year Net Current Assets as percentage of Total Assets of 15.41. As of 12/02/2022, Asset Turnover is likely to grow to 0.30, while Accounts Payable Turnover is likely to drop 4.59.
This module is based on analyzing investor sentiment around taking a position in Clovis Oncology. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Clovis Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Clovis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Clovis Oncology after-hype prediction price

    
  USD 0.3  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Clovis Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Clovis Oncology in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.102.0213.67
Details
Naive
Forecast
LowNext ValueHigh
0.0122250.6112.26
Details
3 Analysts
Consensus
LowTarget PriceHigh
6.007.008.00
Details
Earnings
Estimates (3)
LowProjected EPSHigh
-2.81-2.38-2.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Clovis Oncology. Your research has to be compared to or analyzed against Clovis Oncology's peers to derive any actionable benefits. When done correctly, Clovis Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Clovis Oncology.

Clovis Oncology After-Hype Price Prediction Density Analysis

As far as predicting the price of Clovis Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Clovis Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Clovis Oncology, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Clovis Oncology Estimiated After-Hype Price Volatility

In the context of predicting Clovis Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Clovis Oncology's historical news coverage. Clovis Oncology's after-hype downside and upside margins for the prediction period are 0.02 and 11.95, respectively. We have considered Clovis Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 0.36
0.30
After-hype Price
11.95
Upside
Clovis Oncology is abnormally volatile asset. Analysis and calculation of next after-hype price of Clovis Oncology is based on 3 months time horizon.

Clovis Oncology Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Clovis Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Clovis Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Clovis Oncology, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.70  11.74   0.06   0.18  4 Events / Month0 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.360.3016.67 
14,675  

Clovis Oncology Hype Timeline

Clovis Oncology is currently traded for 0.36. The entity has historical hype elasticity of -0.06 and average elasticity to hype of competition of 0.18. Clovis is anticipated to decline in value after the next headline with the price expected to drop to 0.3. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -16.67% whereas the daily expected return is currently at -0.7%. The volatility of related hype on Clovis Oncology is about 4515.38% with expected price after next announcement by competition of 0.54. About 26.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.13. Clovis Oncology recorded a loss per share of 2.08. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 4 days.
Continue to Clovis Oncology Basic Forecasting Models to cross-verify your projections.

Clovis Oncology Related Hype Analysis

Having access to credible news sources related to Clovis Oncology's direct competition is more important than ever and may enhance your ability to predict Clovis Oncology's future price movements. Getting to know how Clovis Oncology rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Clovis Oncology may potentially react to the hype associated with one of its peers.

Clovis Oncology Additional Predictive Modules

Most predictive techniques to examine Clovis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Clovis using various technical indicators. When you analyze Clovis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Clovis Oncology Predictive Indicators

The successful prediction of Clovis Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Clovis Oncology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Clovis Oncology based on analysis of Clovis Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Clovis Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Clovis Oncology's related companies.
 2021 2022 (projected)
PPandE Turnover15.9617.22
Long Term Debt to Equity3.543.82

Story Coverage note for Clovis Oncology

The number of cover stories for Clovis Oncology depends on current market conditions and Clovis Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Clovis Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Clovis Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Clovis Oncology Short Properties

Clovis Oncology's future price predictability will typically decrease when Clovis Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Clovis Oncology often depends not only on the future outlook of the potential Clovis Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clovis Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding121217000.00
Cash And Short Term Investments143428000.00
Continue to Clovis Oncology Basic Forecasting Models to cross-verify your projections. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for analysis

When running Clovis Oncology price analysis, check to measure Clovis Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clovis Oncology is operating at the current time. Most of Clovis Oncology's value examination focuses on studying past and present price action to predict the probability of Clovis Oncology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Clovis Oncology's price. Additionally, you may evaluate how the addition of Clovis Oncology to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Clovis Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clovis Oncology. If investors know Clovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clovis Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
47.8 M
Quarterly Revenue Growth YOY
(0.19) 
Return On Assets
(0.30) 
The market value of Clovis Oncology is measured differently than its book value, which is the value of Clovis that is recorded on the company's balance sheet. Investors also form their own opinion of Clovis Oncology's value that differs from its market value or its book value, called intrinsic value, which is Clovis Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clovis Oncology's market value can be influenced by many factors that don't directly affect Clovis Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clovis Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine Clovis Oncology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clovis Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.